The Research and Development Team at Avellino spearheads the company's innovative efforts by leveraging genomic data to develop groundbreaking healthcare solutions. This team conducts advanced research in genetics to drive early detection programs in oncology, polygenic risk analysis for glaucoma, and therapeutic solutions like siRNA gene-silencing for granular corneal dystrophy type II. They collaborate closely with bioinformatics, clinical studies, and lab operations to ensure the efficacy and inclusivity of their medical advancements, contributing significantly to global health equity.
View all